Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
2002 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Vitrification in ART: past, present, and future.
Vajta G. Vajta G. Theriogenology. 2020 Jul 1;150:276-279. doi: 10.1016/j.theriogenology.2020.01.057. Epub 2020 Feb 19. Theriogenology. 2020. PMID: 32164991
I am not sure I can make it more interesting, but at least give it a try by focusing on negative events: controversies, fiascos, and absurdities that have hampered the advancement - some of them up till today. I will make efforts to be sincere and sharp; I apologize for th …
I am not sure I can make it more interesting, but at least give it a try by focusing on negative events: controversies, fiascos, and absurdi …
Treatment With Cladribine Selects IFNγ+IL17+ T Cells in RRMS Patients - An In Vitro Study.
Dobreanu M, Manu DR, Mănescu IB, Gabor MR, Huţanu A, Bărcuţean L, Bălaşa R. Dobreanu M, et al. Front Immunol. 2021 Dec 14;12:743010. doi: 10.3389/fimmu.2021.743010. eCollection 2021. Front Immunol. 2021. PMID: 34970256 Free PMC article.
Ex vivo to in vitro phenotype shifts included: decreased CD3+CCR6+ and CD3+CD161+ in all subjects and increased CD3+CXCR3+ in RRMS patients only; Th17.1 showed increased proliferation vs Th17 in all subjects; CD3+IL17+ and CD3+IFNgamma+IL17+ continued to proliferate till d …
Ex vivo to in vitro phenotype shifts included: decreased CD3+CCR6+ and CD3+CD161+ in all subjects and increased CD3+CXCR3+ in RRMS patients …
[Life and works of Gabor Veza, the first protomedicus of Hungary].
Sági E. Sági E. Orvostort Kozl. 2002;47(1-4):157-66. Orvostort Kozl. 2002. PMID: 12814115 Hungarian.
Gabor Veza (1728-1799) was the first "protomedicus Hungariae" (head-physician of Hungary). ...His father had been Josef Veza, an agent of the Habsburg emperor in the Low Countries. Gabor Veza graduated in Toscana in Pisa (1751) later practised medicine in military h
Gabor Veza (1728-1799) was the first "protomedicus Hungariae" (head-physician of Hungary). ...His father had been Josef Veza, an agen
[Malignant non-Hodgkin's lymphoma of the vaginal portion of the uterus ].
Gábor Z, Kolos A. Gábor Z, et al. Orv Hetil. 1989 Sep 24;130(39):2097-8. Orv Hetil. 1989. PMID: 2797792 Hungarian.
No systemic involvement could be established. Cases like this were regarded as being extremely rare till now. In the future however increasing frequency among immunodeficient patients may be expected....
No systemic involvement could be established. Cases like this were regarded as being extremely rare till now. In the future however i …